Alpha Pro Tech (APT) Competitors $4.38 +0.04 (+0.92%) As of 04/30/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock APT vs. LUNG, INGN, TLSI, LNSR, CVRX, BWAY, LAKE, CATX, SGHT, and ZJYLShould you be buying Alpha Pro Tech stock or one of its competitors? The main competitors of Alpha Pro Tech include Pulmonx (LUNG), Inogen (INGN), TriSalus Life Sciences (TLSI), LENSAR (LNSR), CVRx (CVRX), BrainsWay (BWAY), Lakeland Industries (LAKE), Perspective Therapeutics (CATX), Sight Sciences (SGHT), and Jin Medical International (ZJYL). These companies are all part of the "medical equipment" industry. Alpha Pro Tech vs. Pulmonx Inogen TriSalus Life Sciences LENSAR CVRx BrainsWay Lakeland Industries Perspective Therapeutics Sight Sciences Jin Medical International Pulmonx (NASDAQ:LUNG) and Alpha Pro Tech (NYSE:APT) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their community ranking, earnings, profitability, institutional ownership, analyst recommendations, valuation, dividends, media sentiment and risk. Is LUNG or APT more profitable? Alpha Pro Tech has a net margin of 6.99% compared to Pulmonx's net margin of -67.31%. Alpha Pro Tech's return on equity of 6.70% beat Pulmonx's return on equity.Company Net Margins Return on Equity Return on Assets Pulmonx-67.31% -55.36% -33.53% Alpha Pro Tech 6.99%6.70%5.76% Does the MarketBeat Community prefer LUNG or APT? Pulmonx received 4 more outperform votes than Alpha Pro Tech when rated by MarketBeat users. However, 100.00% of users gave Alpha Pro Tech an outperform vote while only 45.57% of users gave Pulmonx an outperform vote. CompanyUnderperformOutperformPulmonxOutperform Votes3645.57% Underperform Votes4354.43% Alpha Pro TechOutperform Votes32100.00% Underperform VotesNo Votes Do analysts prefer LUNG or APT? Pulmonx presently has a consensus price target of $12.75, suggesting a potential upside of 163.98%. Given Pulmonx's stronger consensus rating and higher possible upside, equities research analysts plainly believe Pulmonx is more favorable than Alpha Pro Tech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pulmonx 0 Sell rating(s) 2 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.75Alpha Pro Tech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has stronger earnings & valuation, LUNG or APT? Alpha Pro Tech has lower revenue, but higher earnings than Pulmonx. Pulmonx is trading at a lower price-to-earnings ratio than Alpha Pro Tech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPulmonx$83.79M2.32-$60.84M-$1.44-3.35Alpha Pro Tech$57.84M0.82$4.19M$0.3612.17 Do institutionals & insiders believe in LUNG or APT? 91.0% of Pulmonx shares are held by institutional investors. Comparatively, 22.7% of Alpha Pro Tech shares are held by institutional investors. 6.8% of Pulmonx shares are held by company insiders. Comparatively, 14.0% of Alpha Pro Tech shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has more risk and volatility, LUNG or APT? Pulmonx has a beta of 0.61, meaning that its share price is 39% less volatile than the S&P 500. Comparatively, Alpha Pro Tech has a beta of 0.33, meaning that its share price is 67% less volatile than the S&P 500. Does the media refer more to LUNG or APT? In the previous week, Pulmonx had 11 more articles in the media than Alpha Pro Tech. MarketBeat recorded 11 mentions for Pulmonx and 0 mentions for Alpha Pro Tech. Pulmonx's average media sentiment score of 0.90 beat Alpha Pro Tech's score of 0.00 indicating that Pulmonx is being referred to more favorably in the media. Company Overall Sentiment Pulmonx Positive Alpha Pro Tech Neutral SummaryPulmonx beats Alpha Pro Tech on 10 of the 18 factors compared between the two stocks. Get Alpha Pro Tech News Delivered to You Automatically Sign up to receive the latest news and ratings for APT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart APT vs. The Competition Export to ExcelMetricAlpha Pro TechSurgical appliances & supplies IndustryIndustrials SectorNYSE ExchangeMarket Cap$47.62M$9.15B$7.15B$18.97BDividend YieldN/A1.64%3.56%4.02%P/E Ratio11.8419.2720.9332.71Price / Sales0.8271.1382.5227.84Price / Cash12.8019.6726.9417.53Price / Book0.834.953.754.47Net Income$4.19M$284.66M$807.45M$1.02B7 Day Performance-1.57%0.01%2.45%0.50%1 Month Performance-9.69%1.87%1.63%-2.83%1 Year Performance-27.36%-17.14%14.29%4.36% Alpha Pro Tech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)APTAlpha Pro TechN/A$4.38+0.9%N/A-27.2%$47.62M$57.84M11.84120Analyst ForecastLUNGPulmonx3.1871 of 5 stars$4.52flat$12.75+182.1%-36.5%$181.92M$83.79M-3.14250Earnings ReportUpcoming EarningsNews CoveragePositive NewsINGNInogen2.8157 of 5 stars$6.74-1.2%$7.00+3.9%+4.9%$181.22M$335.71M-3.001,030Upcoming EarningsShort Interest ↑TLSITriSalus Life Sciences3.7659 of 5 stars$5.63-1.9%$11.56+105.4%-44.9%$171.68M$29.43M-2.26106News CoveragePositive NewsGap DownLNSRLENSAR0.9041 of 5 stars$13.79-0.9%$15.00+8.8%+350.3%$162.57M$53.49M-9.45110Upcoming EarningsShort Interest ↑News CoveragePositive NewsCVRXCVRx2.9557 of 5 stars$6.06-3.0%$16.83+177.8%-52.8%$157.78M$51.29M-2.25160Upcoming EarningsShort Interest ↓Positive NewsGap DownBWAYBrainsWay3.2133 of 5 stars$7.86-4.6%$13.17+67.5%+65.1%$148.31M$41.02M78.61120Upcoming EarningsPositive NewsLAKELakeland Industries4.8535 of 5 stars$15.48-0.6%$27.00+74.4%-1.3%$147.05M$167.21M-172.001,800Short Interest ↑Gap UpCATXPerspective Therapeutics3.4633 of 5 stars$1.92-1.0%$12.75+564.1%-85.4%$142.18M$1.43M0.0070SGHTSight Sciences3.6845 of 5 stars$2.76+3.8%$3.83+38.9%-45.0%$141.68M$79.87M-2.71210ZJYLJin Medical InternationalN/A$0.89-5.3%N/A-76.1%$139.33M$23.50M0.00245 Related Companies and Tools Related Companies Pulmonx Competitors Inogen Competitors TriSalus Life Sciences Competitors LENSAR Competitors CVRx Competitors BrainsWay Competitors Lakeland Industries Competitors Perspective Therapeutics Competitors Sight Sciences Competitors Jin Medical International Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:APT) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alpha Pro Tech, Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alpha Pro Tech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy APT Stock Free APT Stock Alerts